French drug company Sanofi and US drug maker Regeneron have conducted joint clinical trials of Kevzara to treat pneumonia caused by the emerging coronavirus.
Especially in Russia, the two companies began testing the drug "Kevzara", which was originally intended to combat rheumatoid arthritis.
The news agency "TASS" Russian news agency "Reuters", today, Monday, that the tests began a week ago in the United States. Now this list has been expanded to include Russia, Italy, Spain, Germany, France and Canada.
Companies tested the effectiveness of the drug "Kevzara" to treat coronavirus, in 300 patients with severe forms of the disease.